Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5 (LGR5) ELISA Kits

Orphan receptor. Additionally we are shipping LGR5 Antibodies (189) and LGR5 Proteins (8) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
LGR5 14160 Q9Z1P4
Anti-Rat LGR5 LGR5 299802  
LGR5 8549 O75473
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top LGR5 ELISA Kits at antibodies-online.com

Showing 2 out of 6 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Mouse 7.81 pg/mL 31.25-2000 pg/mL Typical standard curve 96 Tests 15 to 18 Days
Human 4.69 pg/mL n/a Typical standard curve 96 Tests 15 to 18 Days

More ELISA Kits for LGR5 Interaction Partners

Mouse (Murine) Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5 (LGR5) interaction partners

  1. in the case of intestinal organoids from Lgr5-EGFP-IRES-CreERT2 transgenic mice, in vitro expansion of Lgr5 expression is limited in a culture condition supplemented with essential proteins

  2. NHE8 deficiency resulted in increased Lgr5 expression in the colon.

  3. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.

  4. Results show that Lgr5 is expressed at the neuromuscular junction (NMJ) and is a receptor for Rspo2.

  5. Mex3a defines a reserve-like intestinal stem cell population within the Lgr5+ compartment.

  6. sorted Reg4(+) DCS cells promote organoid formation of single Lgr5(+) colon stem cells. DCS cells can be massively produced from Lgr5(+) colon stem cells in vitro by combined Notch inhibition and Wnt activation

  7. The Lgr5-expressing cells differentiate into hair cells in high yield.

  8. Single-cell transcript profiles reveal multilineage priming in early progenitors derived from Lgr5-expressing intestinal stem cells.

  9. Arrb1 reduced the chemotherapy-induced Lgr5 stem cell apoptosis by inhibiting endoplasmic reticulum stress-mediated mitochondrial apoptotic signaling.

  10. demonstrates that Lgr5 cells give rise to both anterior and posterior taste buds during development, and are capable of regenerating posterior taste buds after injury induced by glossopharyngeal nerve transection

  11. Lgr5(+) chief cells are involved in maintaining the homeostatic stem cell pool. Define Lgr5(+) chief cells as a major cell-of-origin of gastric cancer.

  12. Stem cell plasticity enables hair regeneration following Lgr5(+) cell loss.

  13. role for Lgr5(+) cancer stem cells in primary and metastatic colon cancer

  14. Data show that both the number and relative position of Paneth cells and Lgr5+ cells are important for fission.

  15. RSPO-LGR4/5-ZNRF3/RNF43 module controls metabolic liver zonation and is a hepatic growth/size rheostat during development, homeostasis and regeneration.

  16. adult stem cell marker leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) is expressed in the mice nasal respiratory epithelium.

  17. Employing Lgr5-lacZ transgenic mice and Lgr5 in situ hybridization, authors found colonic epithelial stem cells (CESC) markedly more radioresistant in vivo than small intestinal crypt base columnar stem cells.

  18. Our studies show for the first time that Lgr5 is expressed in the NC cells at embryonic day 9.5 (E9.5) and is maintained during embryonic development and postnataly in the stroma of the ventral tongue, and some areas of the oral mucosa and that Lgr5+ cells participate in the maintenance of the stroma.

  19. Genetic fate-mapping of Alkaline phosphate intestinal(+) cells before or during targeted ablation of Lgr5-expressing stem cells generated numerous long-lived crypt-villus "ribbons," indicative of dedifferentiation of enterocyte precursors into Lgr5(+) stems.

  20. Report targeting LGR5+ tumor stem cells with an antibody-drug conjugate as effective treatment for colon cancer.

Human Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5 (LGR5) interaction partners

  1. In this study, we aimed at the Wnt signaling characteristic of Cancer stem cells (CSC) and designed a liposomal drug delivery system to target CSCs. Liposomes decorated with RSPO1 on the surface were constructed for specific interactions with the Wnt pathway coreceptor LGR5.

  2. The mRNA level of the LGR5 splice variant LGR5Delta5 is an independent negative prognostic marker for overall and disease-specific survival and metastasis in oral squamous cell carcinoma patients.

  3. self-renewal of Lgr5+ stem cells from dissociated single intestinal cells formed organoids that were organized into a 3D structure

  4. An inverse trend was determined between LGR5 up-regulation and TROY down-regulation in gastric cancer tissue.

  5. elevated in invasive breast carcinoma

  6. Though some degree of regenerative response was observed in all cases, LGR5 was highly expressed in chronic liver disease, possibly due to alternate regeneration and reprogramming pathways. LGR5 is predominant in peri-septal hepatocytes rather than epithelial cell adhesion molecule (EpCAM) positive ductular reactions in chronic pediatric liver diseases and may represent a transitional phenotype for the hepatocyte lineage.

  7. this work shows that LGR5 does not vary across the menstrual cycle in healthy and endometriotic eutopic endometria at either RNA or protein levels

  8. expression of CD44 and Lgr5 is related to the malignant biological behavior of colorectal cancer, and they are important factors in promoting local and distant metastases

  9. Data conclude that LGR5 expression in CTCs may serve as a marker for CRC metastasis.

  10. LGR5 is a new functional GSC marker and prognostic indicator that can promote EMT by activating the Wnt/beta-catenin pathway and would thus be a novel therapeutic target for glioma.

  11. Data found LGR5 as a potential target of miR-340. LGR5 was highly expressed in breast cancer cells. Relative expression of LGR5 was negatively regulated by miR-340. Knockdown of LGR5 also inhibited cell proliferation and drug resistance to docetaxel with enhanced cell apoptosis of breast cancer cells.

  12. knockdown of CASC15 significantly inhibited the proliferation, migration and invasion of colon cancer cells in vitro and in vivo. Following mechanistic experiments, CASC15 was observed to act as a sponge to suppress microRNA (miR)4310 that targeted LGR5.

  13. LGR5 overexpression was associated with high T stage and LN metastasis status in breast cancer. High LGR5 expression was also associated with reduced relapse-free survival, indicating that LGR5 may represent a promising prognostic marker for breast cancer patients.

  14. LGR5 is a critical effector of DDX1 in colorectal cancer cells.

  15. Logarithmic expansion of LGR5-expressing cells was observed in human colorectal cancer.

  16. Our findings indicated that the Lgr5High/DCLK1High expression pattern may be considered as a signature phenotype for intestinal subtypes of gastric carcinoma.

  17. Findings suggest a tumor suppressor role for miR-216a in gliomas, which inhibits glioma cell proliferation, migration, and invasion by targeting LGR5.

  18. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.

  19. LGR5 expression in the epithelium and stroma was associated with tumor stage, and by integrating functional experiments with LGR5-sorted cell RNA sequencing data from adenoma and normal organoids, there were correlations between LGR5 and CRC-specific genes, including dickkopf WNT signaling pathway inhibitor 4 (DKK4) and SPARC-related modular calcium binding 2 (SMOC2

  20. LGR5 expression is transiently upregulated during the early stage of cardiomyocyte differentiation from hPSCs, and although LGR5 expression is not required for maintaining hPSCs in the undifferentiated state, knockdown of LGR5 leads to decreased expression of key cardiac transcription factors at the early stage with eventual lack of robust beating cardiomyocytes at the late stage.

LGR5 Antigen Profile

Antigen Summary

Orphan receptor. Stem cell marker of the intestinal epithelium and the hair follicule. Target gene of Wnt signaling.

Gene names and symbols associated with LGR5

  • leucine-rich repeat containing G protein-coupled receptor 5 L homeolog (lgr5.L) antibody
  • leucine rich repeat containing G protein coupled receptor 5 (Lgr5) antibody
  • leucine rich repeat containing G protein-coupled receptor 5 (LGR5) antibody
  • FEX antibody
  • GPR49 antibody
  • GPR67 antibody
  • GRP49 antibody
  • HG38 antibody
  • lgr5-a antibody
  • lgr5a antibody

Protein level used designations for LGR5

leucine-rich repeat-containing G protein-coupled receptor 5 , leucine-rich repeat-containing G-protein coupled receptor 5A , leucine-rich repeat-containing G-protein coupled receptor 5a , G protein-coupled receptor 49 , G-protein coupled receptor 49 , follicle expressed hormone , leucine-rich repeat-containing G-protein coupled receptor 5 , orphan G-protein coupled receptor FEX , G-protein coupled receptor 67 , G-protein coupled receptor HG38 , orphan G protein-coupled receptor HG38

100526795 Xenopus laevis
14160 Mus musculus
299802 Rattus norvegicus
8549 Homo sapiens
427867 Gallus gallus
Selected quality suppliers for LGR5 (LGR5) ELISA Kits
Did you look for something else?